Clinical Trial Update: Beyond TME Origins [NA]

View source ↗

Summary

Imperial College London reports a recruiting cancer trial related to adenocarcinoma; no specific drug names are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma

Snippet

Sponsor: Imperial College London | Conditions: Neoplasms, Adenocarcinoma | NA | Status: RECRUITING